22nd April 2025: Suraksha
Diagnostics Limited, the leading integrated diagnostics chain in Eastern India,
has acquired a majority stake in Fetomat Wellness. Fetomat is one of the
largest Fetal and Maternal Medicine centres in Eastern India for pregnancy
care, prenatal diagnosis, and genetic counselling.
This strategic acquisition merges advanced diagnostics with specialised
prenatal care enabling Suraksha Diagnostics to incorporate the specialized
maternal-fetal services of Fetomat into its extensive diagnostic network. This
in turn enhances the continuum of care for expectant mothers. This partnership
will help in early detection and management of fetal anomalies, high-risk
pregnancies and other prenatal conditions, ensuring better health outcomes for
both the mothers and their babies. The association enables the association of
foetal medicine with genomics for the first time in Eastern India. This brings
the leading edge genomic technology to
be available for patients here. Patients will benefit from the streamlined
access to advanced diagnostics and specialized prenatal care, making certain
timely interventions and better health outcomes.
Dr Somnath Chatterjee, Chairman and Managing Director of Suraksha
Diagnostics Ltd, stated: "Acquiring a majority stake in Fetomat
Wellness aligns with our vision to provide comprehensive healthcare solutions.
This strategic move enhances our capabilities in maternal-fetal medicine,
allowing us to offer integrated services that cater to the evolving needs of
our patients."
Dr. Pradip Goswami, Founder and Director of Fetomat Wellness shared:
"Joining forces with Suraksha Diagnostics marks a significant milestone
for Fetomat. This partnership will amplify our reach and resources, enabling us
to deliver specialized prenatal care to a broader patient base."
The collaboration between Suraksha Diagnostics and Fetomat Wellness
stands for the shared commitment towards the advancement of maternal-fetal
healthcare in Eastern India. By merging diagnostic excellence with specialized
prenatal services, the association is assured to set new standards in women’s
healthcare.
About Suraksha Diagnostics
Established in 1992, Suraksha
Diagnostics has grown into a prominent diagnostics provider, offering a
comprehensive range of over 2,300 tests across pathology, radiology, and
medical consultancy services. The company operates a central reference
laboratory, eight satellite laboratories, 59 diagnostic centres, and 166 sample
collection centres across West Bengal, Bihar, Assam, and Meghalaya. Suraksha's
commitment to technological advancement is evident in its adoption of
AI-enabled smart labs and digital platforms, streamlining operations and
enhancing patient care.
In December 2024, Suraksha completed its Initial Public Offering (IPO),
raising ₹846.25 crore. The IPO was subscribed 1.27 times, reflecting strong
investor confidence in the company's growth trajectory.
About Fetomat Wellness
Founded in 2013 by Dr. Pradip Goswami, Fetomat Wellness has emerged as
a leading centre for maternal-fetal medicine in Eastern India. The centre
offers a comprehensive range of services, including high-risk pregnancy
management, advanced fetal imaging, prenatal diagnostics, genetic counselling,
and infertility treatments such as IVF. With an expert team of medical
professionals, Fetomat has served more than 20,000 patients, establishing
itself as a trusted name in women's healthcare.